BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28009431)

  • 1. Up-regulation of long noncoding RNA CCAL predicts poor patient prognosis and promotes tumor metastasis in osteosarcoma.
    Zhou DK; Yang XW; Li H; Yang Y; Zhu ZJ; Wu N
    Int J Biol Markers; 2017 Mar; 32(1):e108-e112. PubMed ID: 28009431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
    Li F; Cao L; Hang D; Wang F; Wang Q
    Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
    Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
    Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
    Li RZ; Wang LM
    World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
    Chen F; Mo J; Zhang L
    Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
    Li X; Xu R; Liu H; Fang K
    Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
    Zhu B; Cheng D; Li S; Zhou S; Yang Q
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ; Guo XJ; Zhao YM; Fang Y
    Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
    Li X; Wang F; Sun Y; Fan Q; Cui G
    Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
    Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC
    Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linc00460 promotes osteosarcoma progression via miR-1224-5p/FADS1 axis.
    Lian H; Xie P; Yin N; Zhang J; Zhang X; Li J; Zhang C
    Life Sci; 2019 Sep; 233():116757. PubMed ID: 31419446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
    Ruan R; Zhao XL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
    Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
    J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
    Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
    J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.
    Chen J; Zhou J; Chen X; Yang B; Wang D; Yang P; He X; Li H
    Tumour Biol; 2015 Sep; 36(10):8221-9. PubMed ID: 26002578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.
    Niu J; Sun Y; Guo Q; Niu D; Liu B
    Dis Markers; 2016; 2016():7068986. PubMed ID: 27777493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
    Zhang CL; Zhu KP; Shen GQ; Zhu ZS
    Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA CCAL promotes gastric cancer cell proliferation and migration in a Myc dependent way.
    Shan Y; Kong W; Zhu A; Yu P; Xie Q; Zheng S; Jin H
    Pharmazie; 2018 Jan; 73(1):42-48. PubMed ID: 29441950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.